Antifungal Activity of Nonantifungal Drugs

@article{Afeltra2003AntifungalAO,
  title={Antifungal Activity of Nonantifungal Drugs},
  author={Javier Afeltra and Paul E. Verweij},
  journal={European Journal of Clinical Microbiology and Infectious Diseases},
  year={2003},
  volume={22},
  pages={397-407}
}
  • J. Afeltra, P. Verweij
  • Published 26 June 2003
  • Biology
  • European Journal of Clinical Microbiology and Infectious Diseases
The antifungal activity of synthetic, nonchemotherapeutic compounds, antineoplastic agents and antibacterial drugs, such as sulphonamides, has been known since the early 20th century (1932). In this context, the term "nonantifungal" is taken to include a variety of compounds that are employed in the management of pathological conditions of nonfungal infectious etiology but have been shown to exhibit broad-spectrum antifungal activity. In this review, the antifungal properties of compounds such… 

Figures and Tables from this paper

In vitro interactions of amphotericin B and non-antifungal compounds against opportunistic human pathogen Cryptococcus neoformans
TLDR
In this study, the in vitro activity of amantadine, valproic acid, trifluoperazine and chlorpromazine exerted slight antifungal activity against five C. neoformans strains individually and in combination with amphotericin B.
In vitro activity of calcium channel blockers in combination with conventional antifungal agents against clinically important filamentous fungi.
TLDR
The in vitro inhibitory effect of two antiarrhythmic agents, diltiazem and verapamil hydrochloride were tested against different clinical isolates of ascomycetous and mucoralean filamentous fungi and the observed high MICs suggest that these agents could not be considered as alternative systemic antifungal agents.
In Vitro Activity of Amphotericin B in Combination with Statins against Clinical and Environmental Rhizopus oryzae Strains
TLDR
AMB, in combination with ATO and LOV, reacts positively against clinical and environmental R. oryzae isolates and may lead to more effective treatment of mucormycosis and fewer side effects using low dose of AMB.
Susceptibility of clinically important dermatophytes against statins and different statin-antifungal combinations.
The investigation of the antifungal activities of drugs whose primary activities are not related to their antimicrobial potential is in the current forefront of research. Statin compounds, which are
In vitro synergistic interactions of the effects of various statins and azoles against some clinically important fungi.
TLDR
In this study, the in vitro interactions of the effects of various statins and various azole antifungals against different opportunistic pathogenic fungi were investigated using a standard chequerboard broth microdilution method.
Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus species
TLDR
Inhibition of candidal heat shock protein 90 and candidal-specific histone deacetylase represent feasible therapeutic approaches for candidiasis and the correlation of in vitro effects with clinically meaningful in vivo systems is warranted.
Comparison of the effect of non-antifungal and antifungal agents on Candida isolates from the gastrointestinal tract.
TLDR
Trifluoperazine, an antipsychotic drug, exhibited effective antifungal activity with the MFC, comparable to ketoconazole (32 µg/mL), among the three yeast groups, and Candida spp.
Effect of different statins on the antifungal activity of polyene antimycotics
TLDR
The in vitro interactions between polyene antifungal drugs and different statins were evaluated and the extents of inhibition were higher when these compounds were applied together, and as a result the concentrations of amphotericin B and a given statin, needed to prevent fungal growth, could be decreased by some dilution steps.
Synthesis and Antifungal Activity In Vitro of Isoniazid Derivatives against Histoplasma capsulatum var. capsulatum
TLDR
The study showed that the compound alone is able to reduce the ergosterol content of planktonic cells and can alter the membrane permeability of the fungus, and N′-(1-phenylethylidene)isonicotinohydrazide alone or combined with AMB might be of interest in the management of histoplasmosis.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 114 REFERENCES
Potent Synergism of the Combination of Fluconazole and Cyclosporine in Candida albicans
TLDR
Since the Cy concentration effective in vitro is achievable in vivo, the combination of this agent with FLC represents an attractive perspective for the development of new management strategies for candidiasis.
Combinations of antifungal and antineoplastic drugs with interactive effects on inhibition of yeast growth.
TLDR
Drug combinations were selected which inhibit yeast growth at concentrations far below the individual MIC of the drugs, which may prove of value in clinical treatments of cancer patients infected by Candida.
Effectiveness of quinolone antibiotics in modulating the effects of antifungal drugs
TLDR
While the mechanisms of action of the combination of trovafloxacin and amphotericin B or fluconazole are unclear, further work focused on fungal topoisomerase inhibition and the mechanism of the antifungal effect of quinolone antibacterial drugs is warranted.
In Vitro Antifungal Activities of a Series of Dication-Substituted Carbazoles, Furans, and Benzimidazoles
TLDR
Since some of these compounds have been safely given to animals, these classes of molecules have the potential to be developed as antifungal agents.
Antifungal activity of ibuprofen alone and in combination with fluconazole against Candida species.
TLDR
The results point to the practicability of using ibuprofen, alone or in combination with azoles, in the treatment of candidosis, particularly when applied topically, taking advantage of the drug's antifungal and anti-inflammatory properties.
Synergic effects of tacrolimus and azole antifungal agents against azole-resistant Candida albicans strains
TLDR
A number of mechanisms of azole resistance in Candida albicans have already been described, but an energy-dependent drug efflux mechanism in C.Albicans similar to the mechanism described for resistance of cancer cells to anticancer agents is also demonstrated.
Antimicrobial Activities of Mefloquine and a Series of Related Compounds
TLDR
In an attempt to find more active derivatives, 400 mefloquine-related compounds were selected from the chemical inventory of The Walter Reed Army Institute of Research and identified a series of compounds containing a piperidine methanol group attached to pyridine, quinoline, and benzylquinoline ring systems that appear to act by disrupting cell membranes.
Synergistic action of amphotericin B and rifampin against Candida species.
TLDR
Within the genus Candida, synergism of amphotericin B and rifampin appears to be a rather general phenomenon.
Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters
TLDR
It is found that overexpression of the gene encoding 14DM either by gene amplification or by gene deregulation was not the major cause of resistance among these clinical isolates of fluconazole-resistant C. albicans, and that resistance could be mediated by energy-requiring efflux pumps such as ATP-binding cassette (ABC) multidrug transporters.
...
1
2
3
4
5
...